Major Breakthrough in the Production of Anti-Malaria Medicine

Wednesday, 21 February 11:00
Location: Max-Planck-Gesellschaft - Büro Berlin
WissenschaftsForum │ Markgrafenstr. 37 │ 10117 Berlin-Mitte

Scientists of the Max-Planck Institute of Colloids and Interfaces and the Max Planck Institute for Dynamics of Complex Technical Systems in Germany will announce a breakthrough in the field of anti-malaria and cancer treatment.

Researchers have developed a new method using crude compounds and catalysts found in plant waste to produce the powerful drug artemisinin more efficiently than ever before. Artemisinin is the basis for the most effective anti-malaria drugs. This highly-scalable process promises increased, low-cost production and is being industrialized on a massive scale by ArtemiFlow in Kentucky, USA.

“This development has the potential to save millions of lives by increasing the global access and reducing the cost of anti-malaria medicine,” said Prof. Peter H Seeberger who is the Director of the Biomolecular Systems Department, Max-Planck Institute for Colloids and Interfaces.

Currently, 650.000 people die from Malaria every year and 90% of those deaths are children under 5.

A detailed packet will be provided at event or upon request.

Prof. Dr. Peter Seeberger, Director, Max Planck Institute of Colloids and Interfaces

Katja Schulze
Max Planck Institute of Colloids and Interfaces /Public Relations
Tel. +49 331 567 9203

Images and videos for downloading


A short film showing the gas/liquid mixture flowing through
the continuous photoreactor.

The gas and liquid streams meet to create slugs
which move into the photoreactor.

The gas-liquid flow exiting the photoreactor.